Vivo Bio Tech Ltd — Others, 04-08-2025: AGM/EGM

Vivo Bio Tech Limited shareholders have given their approval for an increase in the company's Authorised Share Capital via postal ballot. This strategic move empowers the company with the flexibility to issue new shares in the future, providing a foundational step for potential capital raising initiatives or funding future business expansion. The strong support from shareholders highlights confidence in the company's long-term growth prospects and ability to pursue various corporate actions efficiently.